Related Experiment Video
Updated: Jul 12, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Association of plasma microRNA-16-5p and abdominal aortic calcification in maintenance hemodialysis patients
Qiaojing Liang1, Chen Fu2, Yingjie Liu1
1Department of Nephrology, Faculty of Kidney Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Abstract:
Recent studies have shown that microRNA-16-5p (miR-16-5p) plays a crucial role in the pathological mechanism of vascular calcification. Nevertheless, the expression profile of miR-16-5p in maintenance hemodialysis (MHD) patients who are predisposed to vascular calcification remains unknown. This study aims to investigate the potential associations between calcification risk and serum miR-16-5p expression among MHD patients. This cross-sectional study involved 132 MHD patients from the Dialysis Center of Beijing Friendship Hospital between 1 January 2019 and 31 December 2020. The degree of calcification in MHD patients was assessed using the Abdominal aortic calcification (AAC) score, and miR-16-5p expression was quantified using quantitative real-time polymerase chain reaction (qRT-PCR) with the 2-ΔΔCT method. Statistical analyses, including spearman correlation, linear regression and logistic regression analysis were used to explore the associations between laboratory parameters and AAC score. Calcifications were observed in 79(59.80%) patients. The linear regression showed a one-quartile decrease in miR-16-5p expression led to a significant increase in the AAC score by 5.336 (95% CI: 2.670-10.662, p = 0.000). Multivariate logistic regression analyses revealed that decreased miR-16-5p expression, reduced serum urea nitrogen, elevated white blood cell count, and longer dialysis vintage were significantly associated with an increased incidence of vascular calcification. The Area Under the Curve (AUC) of the Receiver Operating Characteristic (ROC) of the miR-16-5p-based logistic regression model was 0.842 (95% CI: 0.771-0.913, p = 0.000). There was an independent association between miR-16-5p expression and calcification degree. Lower miR-16-5p expression levels seem to be a potential risk factor of vascular calcification in MHD patients.
Insights
Lower microRNA-16-5p (miR-16-5p) levels are linked to increased vascular calcification in maintenance hemodialysis patients. This finding suggests miR-16-5p may be a potential risk factor for this common complication.
Area of Science:
- Biomedical research
- Molecular biology
- Nephrology
Background:
- Vascular calcification is a significant complication in maintenance hemodialysis (MHD) patients.
- microRNA-16-5p (miR-16-5p) is implicated in vascular calcification pathogenesis.
- The role of miR-16-5p in MHD patients with vascular calcification is not well understood.
Purpose of the Study:
- To investigate the association between serum miR-16-5p expression and vascular calcification in MHD patients.
- To determine if miR-16-5p levels can serve as a risk indicator for calcification in this population.
Main Methods:
- Cross-sectional study of 132 MHD patients.
- Assessment of vascular calcification using the Abdominal Aortic Calcification (AAC) score.
- Quantification of serum miR-16-5p expression via quantitative real-time polymerase chain reaction (qRT-PCR).
- Statistical analyses including correlation, linear, and logistic regression.
Main Results:
- Vascular calcification was present in 59.80% of the studied MHD patients.
- A decrease in miR-16-5p expression was significantly associated with higher AAC scores.
- Lower miR-16-5p expression, reduced urea nitrogen, elevated white blood cell count, and longer dialysis vintage were risk factors for vascular calcification.
- The miR-16-5p-based logistic regression model showed a high predictive value (AUC = 0.842).
Conclusions:
- Serum miR-16-5p expression is independently associated with the degree of vascular calcification in MHD patients.
- Low miR-16-5p expression is a potential risk factor for vascular calcification in MHD patients.
- miR-16-5p may represent a novel biomarker for assessing calcification risk in MHD patients.

